All In Biotech

Drug Trial Radar · NCT02269241

Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

Last checked: Nov 19, 2026Latest source record: Aug 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Title says "pivotal". This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,552

Actual

Start

Oct 9, 2014

Primary completion

Oct 4, 2017

Study completion Oct 4, 2017

Sponsor

Lead sponsor
Laboratories Leon Farma, S.A.Industry
Sponsor type
Industry
Collaborators
Chemo France
First posted
Oct 21, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 15 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To demonstrate the contraceptive efficacy of LF111 . To demonstrate the safety and tolerability of LF111 and assessment of pharmacokinetics of LF111.

Conditions

  • Contraception

Interventions

  • LF111 (drospirenone)Drug

    One LF111 tablet once per day for 24 days followed by 4 placebo tablets for 4 days equals one cycle.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Pregnancies (Evaluable Cycles)Time frame: up to 13 months

Locations

37 sites in 1 country. Site status is shown where the registry gives one.

  • Alabama Clinical Therapeutics

    Birmingham, Alabama

  • Anaheim Clinical Trials, LLC

    Anaheim, California

  • WCCT Global

    Costa Mesa, California

  • Women's Health Care Research Corp.

    San Diego, California

  • Downtown Women's Health Care

    Denver, Colorado

  • Horizons Clinical Research Center, LLC

    Denver, Colorado

  • Stamford Therapeutics Consortium

    Stamford, Connecticut

  • Altus Research

    Lake Worth, Florida

  • Miami Research Associates

    Miami, Florida

  • Segal Institute for Clinical Research

    North Miami, Florida

  • Meridien Research - St. Petersburg

    St. Petersburg, Florida

  • Meridien Research - Tampa

    Tampa, Florida

  • Comprehensive Clinical Trials, LLC

    West Palm Beach, Florida

  • Fellows Research Alliance, Inc.

    Savannah, Georgia

  • Rosemark WomenCare Specialists

    Idaho Falls, Idaho

  • Bluegrass Clinical Research, Inc

    Louisville, Kentucky

  • Johns Hopkins School of Medicine

    Baltimore, Maryland

  • Beyer Research

    Kalamazoo, Michigan

  • Lawrence OBGYN Clinical Research, LLC

    Lawrenceville, New Jersey

  • The Center for Women's Health & Wellness, LLC

    Plainsboro, New Jersey

  • Southwest Clinical Research

    Albuquerque, New Mexico

  • NYU School of Medicine

    New York, New York

  • Eastern Carolina Women's Center

    New Bern, North Carolina

  • Wake Research Associates

    Raleigh, North Carolina

  • Hawthorne Medical Research, Inc.

    Winston-Salem, North Carolina

  • University of Cincinnati

    Cincinnati, Ohio

  • Columbus Obstetricians-Gynecology, Inc./Radiant Research, Inc.

    Columbus, Ohio

  • University of Pennsylvania School of Medicine

    Philadelphia, Pennsylvania

  • Clinical Research Of Philadelphia

    Philadelphia, Pennsylvania

  • Fellows Research Alliance, Inc.

    Bluffton, South Carolina

  • Advanced Research Associates

    Corpus Christi, Texas

  • Practice Research Organization

    Dallas, Texas

  • TMC Life Research, Inc.

    Houston, Texas

  • Physicians' Research Options

    Draper, Utah

  • Physicians' Research Options

    Pleasant Grove, Utah

  • Eastern Virginia Medical School

    Norfolk, Virginia

  • Seattle Women's Health, Research, Gynecology

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.